Keywords: PET; SPECT; CT; Radiotracers; HER2; HER3; Metastasis; Breast cancer;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Lymphangioleiomyomatosis; EGFR; HER2; HER3; HER4;
Keywords: HER3; human epidermal growth factor receptor 3; NSCLC; non-small cell lung cancer; HRG; heregulin; EGFR; epidermal growth factor receptor; ITT; intent-to-treat; qRT-PCR; quantitative reverse transcription polymerase chain reaction; Patritumab; Erlotinib;
Keywords: CBL; casitas B-lineage lymphoma; CtxR; cetuximab-resistant; CtxS; cetuximab-sensitive; CRC; colorectal cancer; EGF; epidermal growth factor; EGFR; epidermal growth factor receptor; EMT; epithelial to mesenchymal transition; EPR; epiregulin; FDA; food and
Keywords: Single-molecule fluorescence imaging; Signal transduction; Dynamics; Transforming growth factor β receptor; Epidermal growth factor receptor; Total internal reflection fluorescence microscopy; TGF; transforming growth factor; EGFR; type I epidermal growt
Keywords: HER2; human epidermal growth factor receptor 2; HER3; human epidermal growth factor receptor 3; HRG; heregulin; IGF-1R; insulin-like growth factor-1 receptor; IGF-1; insulin-like growth factor-1; pAKT; phosphorylated AKT; dsIgG; dual-specific IgG; Immunog
Keywords: HER3; Nanobody; in silico; Docking; Peptidomimetic;
EGFR and HER3 signaling blockade in invasive mucinous lung adenocarcinoma harboring an NRG1 fusion
Keywords: Invasive mucinous adenocarcinoma; NRG1; EGFR; HER3;
Survivin-targeting miR-542-3p overcomes HER3 signaling-induced chemoresistance and enhances the antitumor activity of paclitaxel against HER2-overexpressing breast cancer
Keywords: HER3; Survivin; miRNA; Paclitaxel resistance; Breast cancer; RTKs; Receptor tyrosine kinases; PI-3K; Phosphoinositide 3-kinase; CHX; Cycloheximide; ELISA; Enzyme-linked immunosorbent assay; IHC; Immunohistochemistry; i.p.; Intraperitoneal;
Clinical development of HER3-targeting monoclonal antibodies: Perils and progress
Keywords: HER3; Heregulin; Monoclonal antibody; Biomarker;
CCRK is a novel signalling hub exploitable in cancer immunotherapy
Keywords: 9G8; serine and arginine rich splicing factor 7; AKT; AKT serine/threonine kinase; AR; androgen receptor; ARE; androgen response element; ARG1; arginase 1; ATM; ataxia telangiectasia mutated; ATR; ataxia telangiectasia and rad3-related protein; BMDC; mous
Understanding the biology of HER3 receptor as a therapeutic target in human cancer
Keywords: Ab; antibody; ADCC; antibody-dependent cell-mediated cytotoxicity; EGFR; epidermal growth factor receptor; EMT; epithelial-mesenchymal transition; FDA; Food and Drug Administration; HER; Human epidermal growth factor receptor; HRG; heregulin; IGF-1R; insu
Resistance to receptor-blocking therapies primes tumors as targets for HER3-homing nanobiologics
Keywords: HER3; Neuregulin; Target; Tumor; Therapeutic; Nanobiologic; Resistance;
PI3K pathway in prostate cancer: All resistant roads lead to PI3K
Keywords: CRPC; castration-resistant prostate cancer; ADT; androgen deprivation therapy; PI3K; phosphoinositide 3-kinase; AR; androgen receptor; PTEN; phosphatase and tensin homologue deleted on chromosome 10; INPP4B; inositol polyphosphate 4-phosphatase type II; P
Piperlongumine downregulates the expression of HER family in breast cancer cells
Keywords: Breast cancer; HER1; HER2; HER3; Piperlongumine; Reactive oxygen species;
A Highly Diverse and Functional Naïve Ubiquitin Variant Library for Generation of Intracellular Affinity Reagents
Keywords: Ubv; ubiquitin variant; Ub; ubiquitin; wt; wild-type; EGFR; epidermal growth factor receptor; EGF; epidermal growth factor; Her3; human epidermal growth factor receptor 3; NRG; neuregulin; Grb2; growth factor receptor-bound protein 2; GST; glutathione S-t
γ-Tocotrienol-induced disruption of lipid rafts in human breast cancer cells is associated with a reduction in exosome heregulin content
Keywords: γ-Tocotrienol; Exosome; Lipid raft; Breast cancer; HER3; HER4; Heregulin;
Dual targeting of HER3 and EGFR in colorectal tumors might overcome anti-EGFR resistance
Keywords: Colorectal cancer; EGFR; Monoclonal antibodies; Drug resistance; HER3;
The anti-HER3 antibody in combination with trastuzumab exerts synergistic antitumor activity in HER2-positive gastric cancer
Keywords: HER2; HER3; Anti-HER3 antibodies; Trastuzumab; Gastric cancer; ECD; extracellular domain; GC; gastric cancer; HER; human epidermal growth factor receptor; NRG1; neuregulin1; PDX; patient derived xenografts; TGI; tumor growth inhibition;
Development of small molecules targeting the pseudokinase Her3
Keywords: Her3; Pseudokinase; Hydrophobic tagging; Cancer; Pyrazolopyrimidine;
Clinical Translation and Validation of a Predictive Biomarker for Patritumab, an Anti-human Epidermal Growth Factor Receptor 3 (HER3) Monoclonal Antibody, in Patients With Advanced Non-small Cell Lung Cancer
Keywords: Biomarker; Patritumab; Erlotinib; Non-small cell lung cancer; HER3; Heregulin
Mechanisms of and therapeutic approaches for overcoming resistance to epidermal growth factor receptor (EGFR)-targeted therapy in squamous cell carcinoma of the head and neck (SCCHN)
Keywords: Epidermal growth factor receptor; Molecular targeted therapy; Squamous cell carcinoma of the head and neck; Clinical trial; Drug resistance; HER2; HER3;
Novel Hsp90 inhibitor FW-04-806 displays potent antitumor effects in HER2-positive breast cancer cells as a single agent or in combination with lapatinib
Keywords: FW-04-806; HER2; HER3; HER2-positive breast cancer;
The role of HER3 in gastric cancer
Keywords: HER3; Gastric cancer; Monoclonal antibody; MET inhibitor
HER3 expression in patients with primary colorectal cancer and corresponding lymph node metastases related to clinical outcome
Keywords: HER3; Colorectal cancer; Prognosis; Lymph node metastases; IHC; FISH;
Ultrasensitive electrochemical detection of cancer associated biomarker HER3 based on anti-HER3 biosensor
Keywords: HER3; Anti-HER3; Biosensor; Electrochemical impedance spectroscopy; Cancer biomarker;
Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients
Keywords: Breast cancer; HER2-positive; HER3; Trastuzumab;
HER3, serious partner in crime: Therapeutic approaches and potential biomarkers for effect of HER3-targeting
Keywords: HER3; Molecular imaging; Biomarkers; Monoclonal antibodies; Tyrosine kinase inhibitors; Resistance17-AAG, 17-(allylamino)-17-demethoxygeldanamycin; ADCC, ANTIBODY dependent cellular cytotoxicity; CRC, COLORECTAL cancer; Cu, COPPER; EGF, epidermal growth f
HER2/HER3 regulates extracellular acidification and cell migration through MTK1 (MEKK4)
Keywords: MAPK; mitogen-activated protein kinase; ERK; extracellular signal-regulated kinase; MAP3K4; mitogen-activated protein kinase kinase kinase 4; MEKK4; mitogen-activated, extracellular signal-regulated kinase kinase; MTK1; mitogen activated protein three kin
Spheroid Culture of Primary Lung Cancer Cells with Neuregulin 1/HER3 Pathway Activation
Keywords: Primary culture; Non–small-cell lung cancer; EGFR tyrosine kinase inhibitor; Neuregulin 1; HER3
Inhibition of doxorubicin-induced HER3-PI3K-AKT signalling enhances apoptosis of ovarian cancer cells
Keywords: HER3; Doxorubicin; Ovarian cancer; Apoptosis; Chemotherapy
The upgraded role of HER3 and HER4 receptors in breast cancer
Keywords: HER3; HER4; Breast cancer
The role of HER3, the unpretentious member of the HER family, in cancer biology and cancer therapeutics
Keywords: HER3; ErbB3; Resistance; Tyrosine kinase inhibitor
Expression of the epidermal growth factor system in endometrioid endometrial cancer
Keywords: Human endometrium; Endometrial cancer; Endometrioid; HER1; HER2; HER3; HER4; Amphiregulin; TGF-α; HB-EGF; Betacellulin; Epiregulin; EGF; Immunohistochemistry; Real-time PCR
Signaling through ERBB receptors: Multiple layers of diversity and control
Keywords: ERBB: ErbB, erythroblastic leukemia viral oncogene homolog; IR, Insulin receptor; EGFR, Epithelial growth factor receptor.ErbB1; EGFR; ErbB2; HER2/neu; ErbB3; HER3; NRG; Heregulin; EGF; Raft; Cavaolae
Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix
Keywords: EGFR; HER2; HER3; HER4; Cervix cancer;